NEW YORK--(BUSINESS WIRE)-- Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at Jiangbo Pharmaceuticals, Inc. (“JGBO” or the “Company”) (NASDAQ:JGBO - News). Faruqi & Faruqi, LLP seeks to determine whether JGBO and certain of its officers violated the federal securities laws by making false and misleading statements to the Company’s shareholders.
Request more information now by clicking here:www.faruqilaw.com/JGBO
Specifically, the investigation concerns: (1) the Company’s receipt of a subpoena from the U.S. Securities and Exchange Commission on March 26, 2011; (2) the resignation of Audit Committee members Michael Marks and John Wang in response to the Company’s stonewalling of the investigation that resulted from the subpoena; and (3) the sufficiency of the Company’s internal controls and financial statements.
About Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP is a national law firm, representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The firm is focused on providing exemplary legal services in complex litigation. Founded in 1995, the firm maintains its principal office in New York City, with offices in Delaware, California, Florida and Pennsylvania. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP . Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
Contact:
Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Anthony Vozzolo, Esq.
Toll Free: 877-247-4292
Phone: 212-983-9330
（责任编辑：王小楠）
